Phase II Gleevec Idiopathic Hypereosinophilic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00230334
Recruitment Status : Withdrawn (Withdrawn by PI due to insufficient accrual)
First Posted : September 30, 2005
Last Update Posted : April 13, 2011
Information provided by:
Stanford University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given